Biological agents for severe asthma: the evolution of the at-home self-injection approach
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Immunology,Immunology and Allergy
Reference31 articles.
1. Nonadherence to biologic therapies in inflammatory bowel disease;Wentworth;Inflamm Bowel Dis,2018
2. Adherence rates and healthcare costs in Crohn's disease patients receiving certolizumab pegol with and without home health nurse assistance: results from a retrospective analysis of patient claims and home health nurse data;Wolf;Patient Prefer Adherence,2018
3. Chronic disease and self-injection: ethnographic investigations into the patient experience during treatment;Schiff;Rheumatol Ther,2017
4. A portfolio of biologic self-injection devices in rheumatology: how patient involvement in device design can improve treatment experience;van den Bemt;Drug Deliv,2019
5. Severe asthma, biologicals, and auto-injection: yes, no, may be!;Lombardi;Allergy,2020
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of patients’ satisfaction with domiciliary biological treatment in severe asthma: a Portuguese survey;Monaldi Archives for Chest Disease;2024-03-20
2. Self-administration of biologicals for severe asthma: insights for clinicians;Minerva Respiratory Medicine;2024-03
3. Consenso multidisciplinar español sobre las características de los pacientes con asma grave en tratamiento con biológicos susceptibles de pasar a tratamiento domiciliario;Revista Clínica Española;2023-03
4. Spanish multidisciplinary consensus on the characteristics of severe asthma patients on biologic treatment who are candidates for at-home administration;Revista Clínica Española (English Edition);2023-03
5. Six months multicentre pilot open label single‐arm study to evaluate patient experience, acceptability and satisfaction of switching certolizumab pegol from a prefilled syringe or autoinjection pen to an AVA ® e‐Device in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis patients;Journal of Clinical Pharmacy and Therapeutics;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3